You have 9 free searches left this month | for more free features.

mitoxantrone

Showing 1 - 25 of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • (no location specified)
Apr 8, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
Oct 29, 2021

AML Trial in Boston (Etoposide, Cytarabine, Lenalidomide)

Active, not recruiting
  • AML
  • Boston, Massachusetts
  • +2 more
Jan 13, 2021

Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)

Completed
  • Neuromyelitis Optica
  • +3 more
  • Mitoxantrone
  • Buffalo, New York
    Baird Multiple Sclerosis Center
Dec 23, 2020

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)

Completed
  • Non-Hodgkins Lymphoma
  • Fort Myers, Florida
  • +1 more
Feb 21, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 22, 2022

Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)

Terminated
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +37 more
Apr 4, 2022

Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)

Terminated
  • Leukemia
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
Jul 22, 2019

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • +7 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

Acute Myelogenous Leukemia Trial in Boston (Brentuximab Vedotin, Mitoxantrone, Etoposide)

Completed
  • Acute Myelogenous Leukemia
  • Brentuximab Vedotin
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 12, 2020

Medium Dose of Cytarabine and Mitoxantrone

Unknown status
  • Acute Myelogenous Leukemia
  • Chemotherapy
  • Flow Cytometer
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen
Jul 16, 2019

Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)

Recruiting
  • Myeloid Malignancies
  • Magrolimab
  • +6 more
  • Birmingham, Alabama
  • +12 more
Apr 6, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Kansas City (Velcade, Methotrexate, Methotrexate / Hydrocortisone

Terminated
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Kansas City, Missouri
    Children's Mercy Hospital
Jul 23, 2019

Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Mitoxantrone)

Completed
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 18, 2019

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Aug 20, 2021

Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)

Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 10, 2019

Follicular Lymphoma Trial in France (rituximab, fludarabine, mitoxantrone)

Completed
  • Follicular Lymphoma
  • Angers, France
  • +15 more
Aug 22, 2019

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Prostate Cancer Trial in Worldwide (Olaratumab, Mitoxantrone, Prednisone)

Completed
  • Prostate Cancer
  • Olaratumab
  • +2 more
  • Charleroi, Belgium
  • +39 more
Sep 5, 2019

Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in

Terminated
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Los Angeles, California
  • +27 more
Oct 5, 2020

Acute Myeloid Leukaemia Trial in Worldwide (Gemtuzumab ozogamicin, Liposomal daunorubicin, Mitoxantrone)

Recruiting
  • Acute Myeloid Leukaemia
  • Gemtuzumab ozogamicin
  • +6 more
  • Adelaide, Australia
  • +67 more
Sep 30, 2021

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in United States (Crenolanib, Mitoxantrone, Cytarabine)

Completed
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • Little Rock, Arkansas
  • +3 more
May 8, 2019

Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +38 more
Dec 25, 2021